Provides expert guidance on EU MDR 2017/745 compliance, including device classification under Annex VIII, technical documentation structure per Annex II/III, clinical evaluation strategies per Annex XIV, and post-market surveillance planning such as PSUR schedules.
Say it in your own words; the assistant finds this recipe by itself. Examples:
Use this skill when determining the regulatory class of a medical device under the EU MDR, structuring or auditing a technical file for conformity assessment, planning clinical evaluation evidence and CER requirements, or defining post-market surveillance and PSUR frequencies. It is also appropriate for preparing documentation for Notified Body reviews or integrating EUDAMED requirements.
EU MDR compliance patterns for medical device classification, technical documentation, and clinical evidence.
Classify device under MDR Annex VIII:
| Factor | Class I | Class IIa | Class IIb | Class III |
|---|---|---|---|---|
| Duration | Any | Short-term | Long-term | Long-term |
| Invasiveness | Non-invasive | Body orifice | Surgical | Implantable |
| System | Any | Non-critical | Critical organs | CNS/cardiac |
| Risk | Lowest | Low-medium | Medium-high | Highest |
| Information Use | Condition Severity | Class |
|---|---|---|
| Informs decision | Non-serious | IIa |
| Informs decision | Serious | IIb |
| Drives/treats | Critical | III |
Example 1: Absorbable Surgical Suture - Rule 8 (implantable, long-term) - Duration: > 30 days (absorbed) - Contact: General tissue - Classification: Class IIb
Example 2: AI Diagnostic Software - Rule 11 + MDCG 2019-11 - Function: Diagnoses serious condition - Classification: Class IIb
Example 3: Cardiac Pacemaker - Rule 8 (implantable) - Contact: Central circulatory system - Classification: Class III
Prepare technical file per Annex II and III:
ANNEX II TECHNICAL DOCUMENTATION
├── Device description and UDI-DI
├── Label and instructions for use
├── Design and manufacturing info
├── GSPR compliance matrix
├── Benefit-risk analysis
├── Verification and validation
└── Clinical evaluation report
| Requirement | Evidence | Status |
|---|---|---|
| Safe design (GSPR 1-3) | Risk management file | ☐ |
| Chemical properties (GSPR 10.1) | Biocompatibility report | ☐ |
| Infection risk (GSPR 10.2) | Sterilization validation | ☐ |
| Software requirements (GSPR 17) | IEC 62304 documentation | ☐ |
| Labeling (GSPR 23) | Label artwork, IFU | ☐ |
| Class | Route | NB Involvement |
|---|---|---|
| I | Annex II self-declaration | None |
| Is/Im | Annex II + IX/XI | Sterile/measuring aspects |
| IIa | Annex II + IX or XI | Product or QMS |
| IIb | Annex IX, or Annex X + XI | QMS + tech doc assessment, or type exam + production |
| III | Annex IX, or Annex X + XI | Full QMS + product dossier, or type exam + production |
Develop clinical evidence strategy per Annex XIV:
| Class | Minimum Evidence | Investigation |
|---|---|---|
| I | Risk-benefit analysis | Not typically required |
| IIa | Literature + post-market | May be required |
| IIb | Systematic literature review | Often required |
| III | Comprehensive clinical data | Required (Article 61) |
CER CONTENTS
├── Executive summary
├── Device scope and intended purpose
├── Clinical background (state of the art)
├── Literature search methodology
├── Data appraisal and analysis
├── Safety and performance conclusions
├── Benefit-risk determination
└── PMCF plan summary
Establish PMS system per Chapter VII:
| Component | Requirement | Frequency |
|---|---|---|
| PMS Plan | Article 84 | Maintain current |
| PSUR | Article 86 — Class IIa and higher | Per Art. 86(1) schedule below |
| PMCF Plan | Annex XIV Part B | Update with CER |
| PMCF Report | Annex XIV Part B | Annual (Class III) |
| Vigilance | Articles 87-92 | As events occur |
| Class | Frequency (MDR Art. 86(1)) |
|---|---|
| Class III | Updated at least annually |
| Class IIb (all, incl. implantable) | Updated at least annually |
| Class IIa | When necessary, at least every 2 years |
| Class I | No PSUR — PMS report instead (Art. 85) |
| Timeline | Requirement |
|---|---|
| 2 days | Serious public health threat |
| 10 days | Death or serious deterioration |
| 15 days | Other serious incidents |
Implement UDI system per Article 27:
| Module | Content | Actor |
|---|---|---|
| Actor | Company registration | Manufacturer, AR |
| UDI/Device | Device and variant data | Manufacturer |
| Certificates | NB certificates | Notified Body |
| Clinical Investigation | Study registration | Sponsor |
| Vigilance | Incident reports | Manufacturer |
| Market Surveillance | Authority actions | Competent Authority |
Required elements per Article 13:
references/mdr-classification-guide.md contains:
references/clinical-evidence-requirements.md contains:
references/technical-documentation-templates.md contains:
# Quick gap analysis
python scripts/mdr_gap_analyzer.py --device "Device Name" --class IIa
# JSON output for integration
python scripts/mdr_gap_analyzer.py --device "Device Name" --class III --output json
# Interactive assessment
python scripts/mdr_gap_analyzer.py --interactive
Analyzes device against MDR requirements, identifies compliance gaps, generates prioritized recommendations.
Output includes: - Requirements checklist by category - Gap identification with priorities - Critical gap highlighting - Compliance roadmap recommendations
| Factor | Considerations |
|---|---|
| Designation scope | Covers your device type |
| Capacity | Timeline for initial audit |
| Geographic reach | Markets you need to access |
| Technical expertise | Experience with your technology |
| Fee structure | Transparency, predictability |
LICENSESKILL.mdreferences/clinical-evidence-requirements.mdreferences/mdr-classification-guide.mdreferences/technical-documentation-templates.mdscripts/mdr_gap_analyzer.pyVendored from alirezarezvani/claude-skills, commit 27cfcd0fb0a4, path ra-qm-team/skills/mdr-745-specialist, licence MIT. The upstream licence file ships inside the skill.